Literature DB >> 4009497

Nicotine renal excretion rate influences nicotine intake during cigarette smoking.

N L Benowitz, P Jacob.   

Abstract

We examined the hypothesis that rate of elimination of nicotine affects nicotine intake during cigarette smoking. Elimination rate was altered by administering ammonium chloride or sodium bicarbonate throughout the day. Nicotine intake during unrestricted cigarette smoking was measured using metabolic clearance data obtained after i.v. nicotine infusion together with blood and urinary nicotine concentrations measured during 24-hr periods of cigarette smoking. Compared with placebo treatment (urine pH 5.6), urinary acidification (pH 4.5) increased (208%) renal clearance and, to a lesser extent (41%), total clearance and increased (by 7.2 mg) daily urinary excretion of nicotine. Urinary alkalinization (pH 6.7) resulted in a decrease (78%) in renal clearance with a small decrease (3.7 mg) in daily nicotine excretion. Average blood nicotine concentrations were similar in placebo and bicarbonate treatment conditions, but were 15% lower during acid loading. Daily intake of nicotine was 18% greater during acid loading. The compensatory increase in nicotine consumption was only partial, replacing about half the excess urinary nicotine loss. This is the first direct demonstration that rate of elimination can influence self-determined drug consumption in humans.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4009497

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  18 in total

Review 1.  Health consequences of using smokeless tobacco: summary of the Advisory Committee's report to the Surgeon General.

Authors:  J W Cullen; W Blot; J Henningfield; G Boyd; R Mecklenburg; M M Massey
Journal:  Public Health Rep       Date:  1986 Jul-Aug       Impact factor: 2.792

2.  Socioeconomic and drug use determinants of smoking status in an urban adult population of Black African descent.

Authors:  Jill C Mwenifumbo; Edward M Sellers; Rachel F Tyndale
Journal:  Nicotine Tob Res       Date:  2008-08       Impact factor: 4.244

3.  Nicotine metabolism and addiction among adolescent smokers.

Authors:  Mark L Rubinstein; Saul Shiffman; Anna-Barbara Moscicki; Michelle A Rait; Saunak Sen; Neal L Benowitz
Journal:  Addiction       Date:  2012-10-05       Impact factor: 6.526

4.  Development of central and peripheral smoking effects over time.

Authors:  M Hasenfratz; R Nil; K Bättig
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

5.  Health impact of "reduced yield" cigarettes: a critical assessment of the epidemiological evidence.

Authors:  M J Thun; D M Burns
Journal:  Tob Control       Date:  2001       Impact factor: 7.552

Review 6.  Nicotine chemistry, metabolism, kinetics and biomarkers.

Authors:  Neal L Benowitz; Janne Hukkanen; Peyton Jacob
Journal:  Handb Exp Pharmacol       Date:  2009

7.  Effect of cimetidine and ranitidine on the hepatic and renal elimination of nicotine in humans.

Authors:  R Bendayan; J T Sullivan; C Shaw; R C Frecker; E M Sellers
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 8.  Clinical pharmacokinetics of nicotine.

Authors:  C K Svensson
Journal:  Clin Pharmacokinet       Date:  1987-01       Impact factor: 6.447

9.  Nicotine self-administration in mice is associated with rates of nicotine inactivation by CYP2A5.

Authors:  Eric C K Siu; Dieter B Wildenauer; Rachel F Tyndale
Journal:  Psychopharmacology (Berl)       Date:  2006-01-28       Impact factor: 4.530

10.  Mechanistic PBPK Modeling of Urine pH Effect on Renal and Systemic Disposition of Methamphetamine and Amphetamine.

Authors:  Weize Huang; Lindsay C Czuba; Nina Isoherranen
Journal:  J Pharmacol Exp Ther       Date:  2020-03-20       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.